Warm Autoimmune Hemolytic Anemia Associated With Asymptomatic SARS-CoV-2 Infection.

anemia coronavirus disease 2019 (covid-19) severe acute respiratory syndrome coronavirus 2 (sars-cov-2) warm autoimmune hemolytic anemia

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
25 Mar 2021
Historique:
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resultant coronavirus disease 2019 (COVID-19) are associated with several hematologic abnormalities, including immune thrombocytopenia, antiphospholipid syndrome, and autoimmune hemolytic anemia (AIHA). Initial case reports suggested immune dysregulation to be the underlying etiology of SARS-CoV-2-associated AIHA, as all reported cases involved patients with moderate to severe COVID-19, many of whom had underlying lymphoproliferative disorders. More recently, AIHA has been reported in patients with mildly symptomatic SARS-CoV-2 infection. Here, we detail a patient with asymptomatic SARS-CoV-2 infection who presented with severe, symptomatic anemia. Workup was consistent with warm autoimmune hemolytic anemia (WAIHA) secondary to SARS-CoV-2 infection.

Identifiants

pubmed: 33927918
doi: 10.7759/cureus.14101
pmc: PMC8075761
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e14101

Informations de copyright

Copyright © 2021, Liput et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Br J Haematol. 2020 Jul;190(1):31-32
pubmed: 32369626
Clin Lymphoma Myeloma Leuk. 2020 Nov;20(11):774-776
pubmed: 32933879
Blood. 2017 Jun 1;129(22):2971-2979
pubmed: 28360039
Front Immunol. 2020 Jul 10;11:1708
pubmed: 32754163
BMJ Case Rep. 2020 Dec 10;13(12):
pubmed: 33303503
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):690-697
pubmed: 27913548
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):382-389
pubmed: 30504336
Br J Haematol. 2020 Jul;190(1):29-31
pubmed: 32374906
Ann Hematol. 2020 Jul;99(7):1679-1680
pubmed: 32542444

Auteurs

Joseph R Liput (JR)

Internal Medicine, OhioHealth Riverside Methodist Hospital, Columbus, USA.

Kim Jordan (K)

Internal Medicine, OhioHealth Riverside Methodist Hospital, Columbus, USA.

Rini Patadia (R)

Internal Medicine, OhioHealth Riverside Methodist Hospital, Columbus, USA.

Elizabeth Kander (E)

Hematology/Oncology, Columbus Oncology Associates, Columbus, USA.

Classifications MeSH